Match!

Identification of Differentially Expressed Proteins in Triple-Negative Breast Carcinomas Using DIGE and Mass Spectrometry.

Published on Jul 6, 2009in Journal of Proteome Research3.78
· DOI :10.1021/pr900071h
Daniela M. Schulz1
Estimated H-index: 1
,
Claudia Böllner1
Estimated H-index: 1
+ 4 AuthorsMichaela Aubele31
Estimated H-index: 31
Abstract
We compared the protein expression pattern of triple-negative breast carcinomas (HER2−, ER−, PR−) versus those being positive for HER2 and negative for the hormone receptors (HER2+, ER−, PR−) by 2-D DIGE and mass spectrometry. We obtained differential expression patterns for several glycolytic enzymes (as for example MDH2, PGK1, TKT, Aldolase1), cytokeratins (CK7, 8, 9, 14, 17, 19), further structure proteins (vimentin, fibronectin, L-plastin), for NME1-NME2, lactoferrin, and members of the Annexin family. Western blot analysis and immunohistochemistry were conducted to verify the results. The identified marker proteins may advance a more detailed characterization of triple-negative breast cancers and may contribute to the development of better treatment strategies.
  • References (0)
  • Citations (42)
📖 Papers frequently viewed together
200043.07Nature
18 Authors (Charles M. Perou, ..., David Botstein)
10.3k Citations
7,839 Citations
221 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
References0
Newest
Cited By42
Newest
Abstract Nowadays, there are no targeted therapeutic modalities for triple negative breast cancer (TNBC). This disease is associated with poor prognosis and worst clinical outcome because of the aggressive nature of the tumor, delayed diagnosis, and non-specific symptoms in the early stages. Therefore, identification of novel specific TNBC serum biomarkers for screening and therapeutic purposes remains an urgent clinical requirement. New user-friendly and cheap methods for biomarker identificati...
Source
#1Kerstin Tiedemann (McGill University)H-Index: 18
#2Gulzhakhan Sadvakassova (McGill University)H-Index: 3
Last. Svetlana V. Komarova (McGill University)H-Index: 22
view all 9 authors...
Abstract Bone metastasis from breast and prostate carcinomas is facilitated by activation of bone-resorbing osteoclasts. Using proteomics approaches, we have identified peroxiredoxin-4 (PRDX4) as a cancer-secreted mediator of osteoclastogenesis. We now report characterization of L-plastin in the conditioned media (CM) of MDA-MB-231 human breast cancer cells using immunoblotting and mass spectrometry. The osteoclastogenic potential of MDA-MB-231 CM with siRNA-silenced L-plastin was significantly ...
5 CitationsSource
#1Thaise Gonçalves Araújo (UFU: Federal University of Uberlandia)H-Index: 8
#2Douglas Cardoso Brandão (UFU: Federal University of Uberlandia)
Last. Luiz Ricardo Goulart (UFU: Federal University of Uberlandia)H-Index: 26
view all 7 authors...
Abstract Cytokeratins (CK) belong to a large family of intermediate filaments that are primarily expressed in epithelial cells and whose members are expressed in various combinations in normal and malignant entities. In breast cancer (BC), keratin typing is a major tool in tumor histodiagnosis, providing molecular parameters to assess its differentiation status. In our study, we evaluated CK5, CK6, CK8, CK14 and CK18 mRNA levels by qPCR, and CK18, CK5 and CK14 transcripts were effective to diffe...
Source
#1Mengdi Yang (SJTU: Shanghai Jiao Tong University)H-Index: 1
#2Yi Sun (SJTU: Shanghai Jiao Tong University)H-Index: 1
Last. Hui Zhao (SJTU: Shanghai Jiao Tong University)H-Index: 10
view all 9 authors...
Despite recent advances in targeted and immune‐based therapies, the poor prognosis of lung adenocarcinoma (LUAD) with bone metastasis (BM) remains a challenge. First, two‐dimensional gel electrophoresis (2‐DE) was used to identify proteins that were differentially expressed in LUAD with BM, and then matrix‐assisted laser desorption/ionization time of flight mass spectrometry (MALDI‐TOF‐MS) was used to identify these proteins. Second, the Cancer Genome Atlas (TCGA) was used to identify mutations ...
3 CitationsSource
#1Fang LiuH-Index: 3
#2He MengH-Index: 3
Last. Michael C. FitzgeraldH-Index: 34
view all 3 authors...
Proteomic methods for disease state characterization and biomarker discovery have traditionally utilized quantitative mass spectrometry methods to identify proteins with altered expression levels in disease states. Here we report on the large-scale use of protein folding stability measurements to characterize different subtypes of breast cancer using the stable isotope labeling with amino acids in cell culture and stability of proteins from rates of oxidation (SILAC-SPROX) technique. Protein fol...
7 CitationsSource
#1Dongjian Song (Zhengzhou University)H-Index: 3
#2Lifang Yue (Zhengzhou University)H-Index: 3
Last. Jiaxiang Wang (Zhengzhou University)H-Index: 8
view all 18 authors...
ABSTRACTWomen with triple-negative breast cancer (TNBC) have poor prognosis because of the aggressive nature of the tumor, delayed diagnosis and non-specific symptoms in the early stages. Identification of novel specific TNBC serum biomarkers for screening and therapeutic purposes therefore remains an urgent clinical requirement.We obtained serum samples from a total of 380 recruited individuals split into mining and testing sets, with the aim of screening for reliable protein biomarkers from TN...
5 CitationsSource
Epidermal growth factor receptors (EGFRs/HERs) and downstream signaling pathways have been implicated in the pathogenesis of several malignancies including breast cancer and its resistance to treatment with chemotherapeutic drugs. Consequently, several monoclonal antibodies as well as small molecule inhibitors targeting these pathways have emerged as therapeutic tools in the recent past. However, studies have shown that utilizing these molecules in combination with chemotherapy has yielded only ...
8 CitationsSource
#1Namita Pendharkar (B. J. Medical College, Pune)H-Index: 4
#2Akshada GajbhiyeH-Index: 4
Last. Srikanth RapoleH-Index: 11
view all 11 authors...
Worldwide, breast cancer is one of the frequently diagnosed cancers in women with high mortality if not diagnosed at early stage. Although biomarker discoveries through various proteomic approaches have been studied in breast cancer, a limited number of studies have explored the invasive ductal carcinoma with Luminal B HER2 positive (LB) and HER2 enriched (HE) subtypes. The present study employed the complementary quantitative proteomic approaches to find a panel of markers that could discrimina...
13 CitationsSource
#1Julia Beretov (UNSW: University of New South Wales)H-Index: 15
#2Valerie C. Wasinger (UNSW: University of New South Wales)H-Index: 24
Last. Yong Li (UNSW: University of New South Wales)H-Index: 36
view all 6 authors...
Introduction Breast cancer is a complex heterogeneous disease and is a leading cause of death in women. Early diagnosis and monitoring progression of breast cancer are important for improving prognosis. The aim of this study was to identify protein biomarkers in urine for early screening detection and monitoring invasive breast cancer progression. Method We performed a comparative proteomic analysis using ion count relative quantification label free LC-MS/MS analysis of urine from breast cancer ...
34 CitationsSource
#1Hirofumi Matsumoto (SGH: Singapore General Hospital)H-Index: 2
#2Si-Lin KooH-Index: 4
Last. Jabed Iqbal (SGH: Singapore General Hospital)H-Index: 12
view all 5 authors...
Triple negative breast cancer (TNBC) is a heterogenous disease often characterised by aggressive biology and poor prognosis. Efforts to precisely treat TNBC have been compounded by the lack of specific therapeutic molecular targets. Recent transcriptomic studies have revealed, among others, an immunomodulatory subtype of TNBC, whereby activated immune response genes are associated with good prognosis. Since then, a great deal of effort has been made to understand the immune microenvironment of s...
41 CitationsSource